Back to calendar
Larimar Therapeutics, Inc. (LRMR) Earnings
LRMR reports earnings on Tuesday, August 4, 2026
earnings report
August 4, 2026
Q2 2026
Est. EPS: $-0.36
Actual EPS: $-0.30
EPS surprise: 21.35%
Company overview
Market Cap$432.7M
PriceUSD 4.17
EPS (TTM)-2.08
52-week high6.42
52-week low2.71
SectorHealth Technology
IndustryBiotechnology
Employees71